Art
J-GLOBAL ID:201302230717068777   Reference number:13A1412005

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)

HER2陽性進行乳癌のための一次全身療法としてのエピルビシン/シクロホスファミドとその後のドセタキセルとトラスツズマブ併用の多施設第II相試験(HER2NAT試験)
Author (14):
Material:
Volume: 18  Issue:Page: 598-606  Publication year: Aug. 2013 
JST Material Number: L3966A  ISSN: 1341-9625  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1412005&from=J-GLOBAL&jstjournalNo=L3966A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Drug therapy(=pharmacotherapy)for tumors 

Return to Previous Page